Document is current
Any future updates will be listed below
-
Authors
van der Kleij, Maud B. A. https://orcid.org/0009-0008-8492-8039
Meertens, Marinda
Groenland, Stefanie L.
Kordes, Sil
Bergman, Andries M. https://orcid.org/0000-0001-5223-2549
de Feijter, Jeantine M.
Huitema, Alwin D. R.
Steeghs, Neeltje https://orcid.org/0000-0003-2989-2279
,
van der Kleij, Maud B. A.
-
Funding
Funding for this research was provided by:
Ipsen Fund (No grant number, unrestricted grant)
GlaxoSmithKline foundation (No grant number, unrestricted grant)
Novartis (No grant number, unrestricted grant)
Pfizer (No grant number, unrestricted grant)
- License Information
-
More Information
Article History
Received: 27 September 2024
Revised: 14 January 2025
Accepted: 3 February 2025
First Online: 11 February 2025
Competing interests
: MBAvdK, MM, SLG and ADRH declare that they do not have any financial or personal conflicting interests. SK reports travel fees from Janssen. AMB reports research grants from Astellas, Bayer, Sanofi and consultation for Janssen and Novartis. JMdF reports fees for consultancy for Janssen and Merck. NS reports research grants paid to the institute from Abbvie, Actuate Therapeutics, Amgen, Array, Ascendis Pharma, AstraZeneca, Bayer, Blueprint Medicines, Boehringer Ingelheim, BridgeBio, Bristol-Myers Squibb, Cantargia, CellCentric, Cogent Biosciences, Cresecendo Biologics, Cytovation, Deciphera, Dragonfly, Eli Lilly, Exelixis, Genentech, GlaxoSmithKline, IDRx, Immunocore, Incyte, InteRNA, Janssen, Kinnate Biopharma, Kling Biotherapeutics, Luszana, Merck, Merck Sharp & Dohme, Merus, Molecular Partners, Navire Pharma, Novartis, Numab Therapeutics, Pfizer, Relay Pharmaceuticals, Revolution Medicin, Roche, Sanofi, Seattle Genetics, Taiho, Takeda; all outside the submitted work. NS provided consultation or attended advisory boards for Boehringer Ingelheim, Cogent Biosciences, Ellipses Pharma, Incyte, Luszana.
: The DPOG-TDM study was approved by the Institutional Review Board of the Netherlands Cancer Institute (Amsterdam, the Netherlands) (reference number: IRBd20-011). All patients provided written informed consent. The study was performed in accordance with the Declaration of Helsinki.
